PARP1-IN-56 (Compound RCY) is an I-labeled poly(ADP−ribose) polymerase ( PARP1 ) inhibitor. PARP1-IN-56 can be radiolabeled with 211 At or 125 I for use as an α-emitting radiotherapeutic agent. PARP1-IN-56 can be used for the research of cancer [1].
References:
[1]. Reilly SW, et al. Rapid Cu-Catalyzed [ 211 At]Astatination and [ 125 I]Iodination of Boronic Esters at Room Temperature. Org Lett. 2018;20(7):1752-1755.
References:
[1]. Reilly SW, et al. Rapid Cu-Catalyzed [ 211 At]Astatination and [ 125 I]Iodination of Boronic Esters at Room Temperature. Org Lett. 2018;20(7):1752-1755.
















